Renascience Balance Sheet Health
Financial Health criteria checks 5/6
Renascience has a total shareholder equity of ¥1.6B and total debt of ¥365.0M, which brings its debt-to-equity ratio to 23%. Its total assets and total liabilities are ¥2.0B and ¥415.0M respectively.
Key information
23.0%
Debt to equity ratio
JP¥365.00m
Debt
| Interest coverage ratio | n/a |
| Cash | JP¥1.96b |
| Equity | JP¥1.59b |
| Total liabilities | JP¥415.00m |
| Total assets | JP¥2.00b |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4889's short term assets (¥2.0B) exceed its short term liabilities (¥48.0M).
Long Term Liabilities: 4889's short term assets (¥2.0B) exceed its long term liabilities (¥367.0M).
Debt to Equity History and Analysis
Debt Level: 4889 has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 4889's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 4889 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 4889 has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 8.6% each year